Do CRISPR-mediated epigenetic modifications persist long-term in post-mitotic neurons without continuous intervention?

epigenetics open
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
—
Novelty
—
Mechanistic
—
Druggability
—
Priority
75%
Importance
—
Tractability
—
Market price
50%

Description

The debate proposed CRISPRa/CRISPRi approaches for neuroprotective gene regulation but did not address whether epigenetic marks remain stable in non-dividing neurons. This durability question is fundamental to determining dosing strategies and therapeutic feasibility.

Source: Debate session sess_SDA-2026-04-03-gap-crispr-neurodegeneration-20260402 (Analysis: SDA-2026-04-03-gap-crispr-neurodegeneration-20260402)